Viewing Study NCT00131014



Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00131014
Status: RECRUITING
Last Update Posted: 2024-03-05
First Post: 2005-08-15

Brief Title: Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Study Overview

Official Title: Establishing a Tumor Bank and Initial Analysis of Germline and Tumor-Related Genetic Alterations in Families With Multiple Lymphoproliferative Malignancies
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma
Detailed Description: Patients who participate will be asked to complete detailed family and medical history questionnaires initially with a follow-up questionnaire every year
Patients will be asked to supply a blood sample and possibly a mouthwash sample both of which can be done by mail
Patients will be asked to consent to the release of their lymphoma tissue block for the purposes of the study
Patients will be given letters of invitation for their affected relatives to invite them to participate

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None